Utah Medical Products, Inc. (NASDAQ:UTMD) CEO Kevin L. Cornwell sold 7,034 shares of the business’s stock in a transaction dated Thursday, March 8th. The shares were sold at an average price of $91.93, for a total value of $646,635.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Utah Medical Products, Inc. (NASDAQ:UTMD) opened at $93.05 on Friday. The company has a market capitalization of $340.81, a PE ratio of 40.63 and a beta of 0.77. Utah Medical Products, Inc. has a twelve month low of $58.50 and a twelve month high of $94.28.
Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings results on Tuesday, January 30th. The medical instruments supplier reported $0.95 EPS for the quarter. The company had revenue of $10.20 million for the quarter. Utah Medical Products had a return on equity of 18.85% and a net margin of 20.54%.
Separately, BidaskClub upgraded Utah Medical Products from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th.
Several institutional investors have recently modified their holdings of UTMD. Acadian Asset Management LLC bought a new stake in shares of Utah Medical Products in the fourth quarter valued at about $130,000. MetLife Investment Advisors LLC bought a new stake in shares of Utah Medical Products in the fourth quarter valued at about $163,000. SG Americas Securities LLC bought a new stake in shares of Utah Medical Products in the fourth quarter valued at about $189,000. The Manufacturers Life Insurance Company lifted its holdings in shares of Utah Medical Products by 15.4% in the second quarter. The Manufacturers Life Insurance Company now owns 3,355 shares of the medical instruments supplier’s stock valued at $242,000 after purchasing an additional 448 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in shares of Utah Medical Products in the fourth quarter valued at about $289,000. Institutional investors own 67.12% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3255069/kevin-l-cornwell-sells-7034-shares-of-utah-medical-products-inc-utmd-stock.html.
Utah Medical Products Company Profile
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.